Skip to main content
. 2011 May 18;342:d2912. doi: 10.1136/bmj.d2912

Table 3.

 Participants reporting global improvement in symptoms and showing progression of medial tibial and femoral cartilage defects according to insole group. Values are numbers (percentages) unless stated otherwise

Outcome Wedge insoles (n=82) Control insoles (n=85) Relative risk (95 CI)
Global improvement in pain* 57 (70) 55 (64) 1.09 (0.88 to 1.35)
Global improvement in function* 46 (56) 53 (62) 0.91 (0.71 to 1.17)
Progression of medial tibial cartilage defects 13 (16) 18 (21) 0.75 (0.39 to 1.43)
Progression of medial femoral cartilage defects 16 (20) 18 (21) 0.92 (0.51 to 1.68)

*Participants rating themselves as much better or slightly better.